This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Lars Johan Vatten | |
---|---|
Born | |
Nationality | Norwegian |
Known for | Contribution to cancer and perinatal epidemiology |
Scientific career | |
Fields | Epidemiology |
Institutions | Norwegian University of Science and Technology International Prevention Research Institute |
Lars Johan Vatten (born 20 August 1952) is a Norwegian epidemiologist. He has done research on cancer, perinatal and cardiovascular epidemiology.
Vatten was born in Trondheim, Norway, studied Medicine at the University of Tromsø (he was made MD in 1980) and received a Master of Public Health in 1988 from the University of North Carolina. Two years later the University of Trondheim awarded him a PhD.
He initially worked for his internship at the Molde County Hospital from 1980 to 1981 and Sunndal from 1981 to 1982. After serving at the Royal Norwegian Navy he became a family doctor at the University of Trondheim from 1983 to 1986. After a year of training in occupational medicine he joined the Norwegian Cancer Society as a research fellow from 1987-90. In 1990 he changed to the Norwegian Medical Research Council to work there as a scientist in Epidemiology.
In 1996, he became chair of the Epidemiology Department at the Norwegian University of Science and Technology Medical School, a post he still holds. [1] From 1997–2002 he was adjunct lecturer in cancer epidemiology at the Harvard School of Public Health in Boston, US. He also was Professor in Epidemiology at the University of Bergen, Norway, from 2002–2003 and a senior research fellow at the International Agency for Research on Cancer, Lyon, from 2007 to 2008. Since 2008 Lars Vatten holds an honorary professorship at Bristol University and is a visiting scientist of the Harvard School of Public Health (now Harvard T.H. Chan School of Public Health) since 2009. Since 2010 Lars Vatten has become a senior research fellow of the International Prevention Research Institute, Lyon, France.
Vatten's specific field of research is epidemiological research. He has contributed to the fields of cancer, perinatal and cardiovascular epidemiology.
He has published more than 200 articles in scientific journals [2] and is co-author of some books.[ which? ]
Lars Vatten is a Member of The Royal Norwegian Society of Sciences and Letters.
He received in 2010 the King Olav V's Prize for Cancer Research from the Norwegian Cancer Society. [3] [4]
Sir William Richard Shaboe Doll was a British physician who became an epidemiologist in the mid-20th century and made important contributions to that discipline. He was a pioneer in research linking smoking to health problems. With Ernst Wynder, Bradford Hill and Evarts Graham, he was credited with being the first to prove that smoking increased the risk of lung cancer and heart disease.
The Harvard T.H. Chan School of Public Health is the public health school of Harvard University, located in the Longwood Medical Area of Boston, Massachusetts. The school grew out of the Harvard-MIT School for Health Officers, the nation's first graduate training program in population health, which was founded in 1913 and then became the Harvard School of Public Health in 1922.
Paul M. Ridker is a cardiovascular epidemiologist and biomedical researcher. He is currently the Eugene Braunwald Professor of Medicine at Harvard University and Brigham and Women's Hospital, where he directs the Center for Cardiovascular Disease Prevention. Ridker also holds an appointment as Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health.
Graham Andrew Colditz MD, DrPH is an Australian chronic disease epidemiologist. He is the inaugural Niess-Gain Professor at Washington University School of Medicine, where he is associate director for Prevention and Control at the Alvin J. Siteman Cancer Center. He directs the Master of Population Health Science at Washington University School of Medicine. During medical training he was excited by the potential for prevention of chronic diseases. With encouragement from mentors he pursued training in the US as it was routine for academics in Australia to obtain overseas training at that time. He is internationally recognized for leadership in cancer prevention, and is often interviewed by media for input on this topic. With members of Cancer Prevention and Control at Siteman, he blogs on issues relating to cancer prevention and screening. According to Google Scholar statistics, Colditz has a h-index of more than 300.
Joseph F. Fraumeni Jr. is an American physician and cancer researcher. Born in Boston, he received an A.B. from Harvard College, an M.D. from Duke University, and an M.Sc. in epidemiology from the Harvard School of Public Health. He completed his medical residency at Johns Hopkins Hospital and Memorial Sloan-Kettering Cancer Center. He then joined the National Cancer Institute at the National Institutes of Health in 1962 as a commissioned officer of the U.S. Public Health Service, becoming the founding Director of the Division of Cancer Epidemiology and Genetics in 1995. He stepped down from this position in 2012 to become a senior investigator and advisor to the National Cancer Institute.
JoAnn Elisabeth Manson is an American physician and professor known for her pioneering research, public leadership, and advocacy in the fields of epidemiology and women's health.
Peter Boyle, FRSE FFPH FRCPS(Glas) FRCP(Edin) FMedSci, was a British epidemiologist. He conducted research on globalisation of cancer, where he showed the dramatic increase of cancer in low- and medium income countries.
Paolo Boffetta is an Italian epidemiologist. He is doing research on cancer and other chronic diseases, where he contributed to the understanding of the role of occupation, environment, alcohol, smoking and nutrition in disease development.
Carlo La Vecchia is an Italian epidemiologist. He is doing research on chronic diseases, where he contributed to the understanding of the risks related to diet, tobacco, oral contraceptive use and occupational or environmental exposure to toxic substances in cancer and other chronic diseases development.
K. Srinath Reddy is an Indian physician and the Former President of the Public Health Foundation of India and formerly headed the Department of Cardiology at All India Institute of Medical Sciences (AIIMS).
Clement Adebamowo is a Nigerian medical researcher and academic. Born in Lagos, Nigeria, Adebamowo is currently Director For Global Health Cancer Research, and a professor of Epidemiology & Public Health, at the University of Maryland School of Medicine. He is known for his work in cancer epidemiology, nutrition epidemiology, and research ethics, particularly in low resource and under-served in Africa.
Dimitrios Trichopoulos, was a Mediterranean Diet expert and tobacco harms researcher. He was Vincent L. Gregory Professor of Cancer Prevention and Professor of Epidemiology, and a past chair of the Department of Epidemiology, in the Harvard School of Public Health in Boston.
Michael B. Bracken, Ph.D., M.Phil., M.P.H., is a perinatal epidemiologist. He is the Susan Dwight Bliss Professor of Epidemiology at the Yale School of Public Health, and Professor of Obstetrics, Gynecology and Reproductive Sciences, and Professor of Neurology at the Yale School of Medicine. He is co-director of the Yale Center for Perinatal, Pediatric and Environmental Epidemiology.
Dr. Moyses Szklo is a Brazilian epidemiologist and physician scientist. He is currently University Distinguished Service Professor of Epidemiology and Medicine at the Johns Hopkins University, Editor-in-chief Emeritus of the American Journal of Epidemiology, and director of the Johns Hopkins Summer Institute of Epidemiology and Biostatistics. Szklo has published over 300 articles in peer-reviewed journals as well as a major textbook of epidemiology. He has led several major epidemiologic societies and studies and has been lecturing and leading courses all over the world, including Spain, Italy, Israel, Brazil, and Mexico.
David John Hunter is an Australian epidemiologist and the Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health. He was previously a professor in Harvard University's departments of Epidemiology and Nutrition. Hunter was associate epidemiologist, Channing Laboratory, Brigham and Women's Hospital, where he was involved with the programs in breast cancer, cancer epidemiology, and cancer genetics research teams. At Oxford he directs the Translational Epidemiology Unit and leads a collaborative project between Oxford and the Harvard T.H. Chan School of Public Health.
Anne B. Newman M.D., M.P.H, is a scientist who researches Epidemiology and Gerontology. She received her Bachelor's, Master's and M.D. degrees from the University of Pittsburgh. Dr. Newman's primary focus of study is on atherosclerosis, longevity and what specific factors allow for people to thrive while aging. She is well-versed in the subjects of cardiovascular disease, sarcopenia, and the body's physical and mental functions. Born in Pennsylvania, the American research scientist focuses on Geriatrics, Gerontology and Epidemiology. She was the first scholar to be awarded the Katherine M. Detre Endowed Chair of Population Health Science at the University of Pittsburgh. She is widely published and has been listed on the annual ISI Web of Knowledge most highly cited scientists for 2015, as published by Thomson Reuters. Newman is a member of the Delta Omega Honor Society in Public Health and the American Epidemiology Society. Dr. Newman's highest qualifications are in geriatric medicine and her certification is through the American Board of Internal Medicine. Newman lives in Point Breeze Pennsylvania with her husband, Frank Kirkwood. She is a mother of three to Dan, Joe, and Bridget.
Simin Liu is an American physician researcher. He holds leadership positions internationally in the research of nutrition, genetics, epidemiology, and environmental and biological influences of complex diseases related to cardiometabolic health in diverse population. His research team has uncovered new mechanisms and risk-factors as well as developed research frameworks for diabetes and cardiovascular diseases. Liu's laboratory conducts research mainly in the United States, though the group has had research collaborations, teaching, and service activities in six of the Seven Continents.
Adele Chandler Green is an Australian epidemiological senior scientist at the QIMR Berghofer Medical Research Institute in Brisbane and is the institute's Head of Cancer and Population Studies Group.
Deborah A. Lawlor is a British epidemiologist and professor at the University of Bristol, where she is the deputy director of the Medical Research Council Integrative Epidemiology Unit. She is also a fellow of the Faculty of Public Health and of the Academy of Medical Sciences. Her main areas of research are perinatal, reproductive and cardio-metabolic health. Lawlor was awarded a CBE in the 2017 Queen's Birthday Honours for her services to social and community medicine research.
Camara Phyllis Jones is an American physician, epidemiologist, and anti-racism activist who specializes in the effects of racism and social inequalities on health. She is known for her work in defining institutional racism, personally mediated racism, and internalized racism in the context of modern U.S. race relations. During the COVID-19 pandemic, Jones drew attention to why racism and not race is a risk factor and called for actions to address structural racism.